We are live on ! Find out more
INAB icon

IN8bio
INAB

21 hedge funds and large institutions have $2.58M invested in IN8bio in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 3 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

167% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 3

0% more ownership

Funds ownership: 0.26% → 0.26% (+0%)

5% less funds holding

Funds holding: 22 → 21 (-1)

25% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 4

28% less capital invested

Capital invested by funds: $3.59M → $2.58M (-$1.01M)

Holders
21
Holders Change
-1
Holders Change %
-4.55%
% of All Funds
0.33%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
8
Reduced
3
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RCG
Rock Creek Group
District of Columbia
+$93.8K
2
VC
Voss Capital
Texas
+$67.1K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$64K
4
TCBWMS
Texas Capital Bank Wealth Management Services
Texas
+$53.1K
5
BCM
Bridgeway Capital Management
Texas
+$36.6K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$88.9K
2
Renaissance Technologies
Renaissance Technologies
New York
-$33K
3
Two Sigma Investments
Two Sigma Investments
New York
-$28K
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$27.1K
5
BlackRock
BlackRock
New York
-$19.2K

INAB Hedge Fund Activity: Q3 2023 in Review

21 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in IN8bio (INAB) for Q3 2023, worth a combined $2.58M — down 28% from $3.59M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of INAB and 3 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 8 added.

The largest buyer was Rock Creek Group, adding an estimated $93.8K. The largest seller was Citadel Advisors, exiting entirely with an estimated $88.9K sold.

  • 21 institutional investors held IN8bio (INAB) as of Q3 2023, down from 22 in Q2 2023.
  • Funds reported $2.58M of IN8bio stock for Q3 2023, down 28% quarter-over-quarter.
  • 3 funds opened new IN8bio positions in Q3 2023 and 4 closed out, a net change of -1 holder.
  • The largest IN8bio buyer in Q3 2023 was Rock Creek Group, an estimated $93.8K added.
  • The largest IN8bio seller in Q3 2023 was Citadel Advisors, an estimated $88.9K sold.

Based on aggregated 13F filings for Q3 2023.